Abstract:The opioid epidemic is an evolving health crisis in need of interventions that target all domains of maladaptive changes due to chronic use and abuse. Opioids are known for their effects on the opioid and dopaminergic systems, in addition to neurocircuitry changes that mediate changes in behavior; however, new research lines are looking at complementary changes in the brain and gut. The gut-brain axis (GBA) is a bidirectional signaling process that permits feedback between the brain and gut and is altered in subjects with opioid use disorders. In this work, we determine longitudinal, non-invasive, and in-vivo complementary changes in the brain and gut in rodents trained to self-administer morphine for two weeks using MRI and 16S rDNA analysis of fecal matter. We assess the changes occurring during both an acute phase (early in the self-administration process, after two days of self-administration) and a chronic phase (late in the self-administration process, after two weeks of self-administration), with all measurements benchmarked against baseline (naïve, non-drug state). Rats were surgically implanted with an intravenous jugular catheter for self-administration of morphine. Rats were allowed to choose between an active lever, which delivers a single infusion of morphine (0.4 mg/kg/infusion), or an inactive lever, which had no consequence upon pressing. Animals were scanned in a 7T MRI scanner three times (baseline, acute, and chronic), and before scanning, fecal matter was collected from each rat. After the last scan session, a subset of animals was euthanized, and brains were preserved for immunohistochemistry analysis. We found early changes in gut microbiota diversity and specific abundance as early as the acute phase that persisted into the chronic phase. In MRI, we identified alterations in diffusivity indices both within subjects and between groups, showing a main effect in the striatum, thalamus, and somatosensory cortex. Finally, immunohistochemistry analyses revealed increased neuroinflammatory markers in the thalamus of rats exposed to morphine. Overall, we demonstrate that morphine self-administration shapes the brain and gut microbiota. In conclusion, gut changes precede the anatomical effects observed in MRI features, with neuroinflammation emerging as a crucial link mediating communication between the gut and the brain. This highlights neuroinflammation as a potential target in addressing the impacts of opioid use.

The Association of Altered Gut Microbiota and Intestinal Mucosal Barrier Integrity in Mice with Heroin Dependence

Long access heroin self-administration significantly alters gut microbiome composition and structure

Determination of Metabolic Phenotype and Potential Biomarkers in the Liver of Heroin Addicted Mice with Hepatotoxicity.

Exploring the role and mechanism of gut microbiota in methamphetamine addiction using antibiotic treatment followed by fecal microbiota transplantation

Characterized Profiles of Gut Microbiota in Morphine Abstinence-Induced Depressive-Like Behavior

Methadone Maintenance Treatment is More Effective Than Compulsory Detoxification in Addressing Gut Microbiota Dysbiosis Caused by Heroin Abuse

Differential alteration in gut microbiome profiles during acquisition, extinction and reinstatement of morphine-induced CPP

Metabolic Phenotype of Rats Exposed to Heroin and Potential Markers of Heroin Abuse

Integration of Molecular Inflammatory Interactome Analyses Reveals Dynamics of Circulating Cytokines and Extracellular Vesicle Long Non-Coding RNAs and Mrnas in Heroin Addicts During Acute and Protracted Withdrawal

Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing

Transcriptomics and Metabolomics Together Reveal the Underlying Mechanism of Heroin Hepatotoxicity

Reversible Brain White Matter Microstructure Changes in Heroin Addicts: A Longitudinal Study

Gut Microbiota Modulates Alcohol Withdrawal-Induced Anxiety in Mice

Fecal microbiota transplantation repairs intestinal permeability and regulates the expression of 5-HT to influence alcohol-induced depression-like behaviors in C57BL/6J mice

Alterations in the oral microbiome and metabolome of methamphetamine addicts

Identification of Morphine and Heroin-Treatment in Mice Using Metabonomics

Alterations in Gut Microbiota Affect Behavioral and Inflammatory Responses to Methamphetamine in Mice

Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder

Gut Microbiota and DTI Microstructural Brain Alterations in Rodents Due to Morphine Self-Administration

Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice